Global Biopolitics Research Group, Department of Political Economy, King's College London, Strand, London, WC2R 1HH, UK.
Transgenic Res. 2013 Feb;22(1):5-13. doi: 10.1007/s11248-012-9648-5. Epub 2012 Sep 18.
Despite being both Genetically Modified Organisms (GMOs), GM plants and GM animals share few similarities outside the laboratory premises. Whilst GM plants were soon embraced by industry and became a commercial success, only recently have GM animals reached the market. However, an area where GM animals are likely to follow the GM plant path is on their potential to cause social unrest. One of the major flaws of the 90s GMO crisis was the underestimation of the influence that different players can have in the adoption of new biotechnological applications. In this article we describe the unique evolution of GM animals in two of the most important fields: the pharmaceutical and the breeding sectors. For our analysis, we have subdivided the production chain into three governance domains: Science, Market and Public. We describe the influence and interaction of each of these domains as a vehicle for predicting the future adoptability of GM animals and to highlight conflicting areas.
尽管同为基因改造生物（GMOs），在实验室以外的环境下，基因改造植物和动物之间几乎没有相似之处。虽然基因改造植物很快被业界所接受并取得商业上的成功，但直到最近，基因改造动物才进入市场。然而，基因改造动物在某些方面可能会追随基因改造植物的发展轨迹，那就是它们可能会引发社会动荡。20 世纪 90 年代的 GMO 危机的主要缺陷之一是低估了不同参与者在采用新生物技术应用方面的影响力。在本文中，我们描述了在两个最重要的领域——制药和养殖领域——中基因改造动物的独特演变。对于我们的分析，我们将生产链细分为三个治理领域：科学、市场和公众。我们描述了这些领域中的每一个领域的影响和相互作用，以此作为预测基因改造动物未来采用率的工具，并突出冲突领域。
